We strive to Elevate your Leadership Journey

Being a CEO can be very lonely and LifeScience ORG provides a large community of other CEOs who are on that same journey and going through the same challenges. It is a safe space where CEOs can ask all the difficult questions in a confidential and trusted setting and get all the answers from the speakers and other members in the community.

The speakers are either all well-known life science leaders or thought leaders from the leading business schools and the exchange of insights and experiences during the discussions is really best-in-class.

The largely virtual format also fits perfectly into my crowded CEO agenda. LifeScience ORG really is quite unique as such.
— Nawal Ouzren - CEO Sensorion (Paris, France)

Ways to Engage

  • INSIGHTS – High-Impact Keynotes

Learn from the best. World-class thought leaders and seasoned CEOs share critical strategies on leadership, scaling, and transformation in structured keynotes. All sessions are recorded and available 24/7—so you can access them anytime.

  • CEO CLINICS – Unfiltered, Closed-Door Conversations

When you need candid, real-world advice, CEO Clinics bring small groups together under Chatham House rules. A seasoned leader shares their hard-won lessons, and nothing is recorded—so you get unfiltered insights in a confidential space.

  • MASTERMIND – Wins, Losses & Lessons Over Lunch

CEOs discuss the real stories behind their latest successes—or setbacks. These informal, open sessions create a space for practical knowledge-sharing and fresh perspectives, helping you turn experience into strategy.

  • FORUM – A Trusted Inner Circle for Deep-Dive Challenges

For CEOs who want ongoing peer support, Forums provide a small, fixed group setting where leaders tackle critical challenges together. Supported by an expert coach, these sessions offer structured, strategic problem-solving with peers who truly understand your world.

  • reTREATs @ Major Conferences – Your Private CEO Hub

    Our ReTREATs at major events provide an exclusive space where you can:
    ✔️ Host important investor or partner meetings
    ✔️ Connect with fellow CEOs in a relaxed, private setting
    ✔️ Catch up on emails or reset between sessions

INSIGHTS:

A Sneak Peek into Our Community

Upcoming Events

INSIGHTS/ The CEO: Peer Schatz - When Leadership Falls Short: Strategies to Address Underperformance in the Boardroom
Apr
29

INSIGHTS/ The CEO: Peer Schatz - When Leadership Falls Short: Strategies to Address Underperformance in the Boardroom

Peer Schatz - Managing Director at PS Capital Management

Peer M. Schatz has spent decades working with boards, as a CEO, Board Chair and NED. His experience spans governance structures, investor relations, and strategic engagement, making him uniquely positioned to discuss how you can drive board performance.

View Event →
INSIGHTS/ Death of the Pitch Deck - Chris Tomlin and Richard Barnes (Hype Presentations)
Apr
30

INSIGHTS/ Death of the Pitch Deck - Chris Tomlin and Richard Barnes (Hype Presentations)

Chris Tomlin & Richard Barnes - Hype Presentations

Chris is a storytelling strategist with a background in copywriting, sales, and business development, focused on shaping clear, investor-ready narratives. Richard is a presentation specialist with over two decades of experience, known for combining visual design, narrative structure, and technology to communicate ideas with clarity and impact. Their work at Hype Presentations spans hundreds of campaigns, from early-stage startups to global brands such as UEFA, BBC, Dell, and Unilever.

View Event →

MASTERMIND: Lisa Deschamps (AviadoBio) & Joe Sandys (Cooley LLP): AviadoBio’s $2.18 Billion Gene Therapy Agreement with Astellas
Mar
20

MASTERMIND: Lisa Deschamps (AviadoBio) & Joe Sandys (Cooley LLP): AviadoBio’s $2.18 Billion Gene Therapy Agreement with Astellas

Lisa Deschamps - CEO of AviadoBio

Joe Sandys - Special Counsel at Cooley (UK)

Tom Goodman - Partner at Cooley (UK)

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

View Event →
INSIGHTS/ The CEO: Jonathan Montagu, Co-Founder and CEO of HotSpot Therapeutics – Do Transatlantic Ventures have a USP?
Mar
4

INSIGHTS/ The CEO: Jonathan Montagu, Co-Founder and CEO of HotSpot Therapeutics – Do Transatlantic Ventures have a USP?

Jonathan Montagu - Co-Founder & CEO of HotSpot Therapeutics

Before founding HotSpot, Jonathan worked at Atlas Venture, where he helped launch and build early-stage biotech companies. He also served as Chief Business Officer at Nimbus Therapeutics, where he helped structure key partnerships, and as Vice President of Business Development at Concert Pharmaceuticals. 

Jonathan holds a degree in chemistry from Oxford University and an MBA from Stanford Graduate School of Business.

View Event →
reTREAT @ JP Morgan '25
Jan
13
to Jan 16

reTREAT @ JP Morgan '25

Those who came last year know that we have a wonderful space for our members in San Francisco.

Harry M. Smith Conference Room at Union Square
414 Mason St. 8th Floor, Suite 800,
San Francisco, CA, 94102

We will be open for meetings from 7am - 6pm Monday - Wednesday.

View Event →
INSIGHTS/ The Expert: Jeff Berkowitz (CEO Real Endpoints Inc.) - Market Access & The U.S.
Dec
16

INSIGHTS/ The Expert: Jeff Berkowitz (CEO Real Endpoints Inc.) - Market Access & The U.S.

Jeff Berkowitz - CEO Real Endpoints Inc.

Jeff is a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with a concentrated focus on value based arrangements, patient services and market access support for pharmaceutical manufacturers and payors. 

View Event →
MASTERMIND: Catherine Pickering (iOnctura) / Roel Bulthuis (Syncona) - Raising a €80 mil Series B round for iOnctura
Dec
11

MASTERMIND: Catherine Pickering (iOnctura) / Roel Bulthuis (Syncona) - Raising a €80 mil Series B round for iOnctura

Catherine Pickering - CEO of iOnctura

Roel Bulthuis - Managing Partner and Head of Investments of Syncona Investment Management Ltd

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

View Event →
INSIGHTS/ The Experts: François Candelon & Leonid Zhukov (BCG Henderson Institute) - How can GenAI expand your workforce?
Oct
16

INSIGHTS/ The Experts: François Candelon & Leonid Zhukov (BCG Henderson Institute) - How can GenAI expand your workforce?

François Candelon & Leonid Zhukov - BCG Henderson Institute

François Candelon is currently a Partner at Seven2, a French private equity firm. Previously, he served as the Global Director of the BCG Henderson Institute (2019-2024).

Leonid Zhukovis the Director of the BCG Global AI Institute, where he plays a pivotal role in exploring how artificial intelligence, particularly generative AI (GenAI), can transform industries.

View Event →
INSIGHTS/ The Expert: Cyril Peupion - Challenging your productivity: Work Smarter / Live better
Jul
16

INSIGHTS/ The Expert: Cyril Peupion - Challenging your productivity: Work Smarter / Live better

Cyril Peupion - Team Well-Being and Productivity Expert & Author

Cyril is a thought leader in the areas of productivity, time management and work life balance. As one of the world’s leading experts on productivity, Cyril supports executives, leaders and teams to improve performance & work life balance by changing work habits.

View Event →
INSIGHTS/ The Expert: Elaine V. Jones (NED and Board Chair) - Managing an investor-dominated board
Jun
25

INSIGHTS/ The Expert: Elaine V. Jones (NED and Board Chair) - Managing an investor-dominated board

Dr. Elaine V. Jones - NED and Board Chair

Dr. Jones currently serves on the boards of the publicly traded companies CytomX (NASDAQ: CTMX), HBM Healthcare Investments AG (SIX: HBMN), and NextCure (NASDAQ: NXTC), and is the Chair of Gritstone bio (NASDAQ: GRTS). In addition, Dr. Jones is Chair of Mironid, a privately held UK company (Edinburgh, Scotland) focused on new treatments for degenerative kidney disease, and serves as a Director of Myeloid Therapeutics (Cambridge, MA), a private company developing products to reprogram myeloid cells for cancer therapy. She also serves on the advisory board of the Novartis Venture Fund and as a member of the Cancer Prevention and Research Institute of Texas (CPRIT) Product Development Review Council.

View Event →